Latest News
A study has discovered that giving early breast cancer patients’ palbociclib alongside hormone treatment stopped tumor growth entirely.
Potentially practice-changing data was presented at 2018 ASH Annual Meeting and Exposition (December 1–4, 2018; CA, USA), read our round-up to discover the key studies. Highlights include the CASSINI and MAIA trial data,
A report from the Institute of Cancer Research has found that cancer patients are waiting longer than ever for access to innovative drug treatments.
Journal Articles
Erickson and colleagues evaluated hydration requirements with emetogenic chemotherapy and investigated the effects of an antiemetic drug combination.
Authors discuss the results of this observational real-world study and how sequencing tyrosine kinase inhibitors can extend chemotherapy-free treatment time.
In this review article from Future Oncology find out about the PACIFIC trial design as well as the future of immunotherapy combinations and biomarkers beyond PD-L1.
Brain and neurologic
NCRI 2018: Fluorescent marker helps improve accuracy of brain tumor cell removal
Zika vaccine yields promising results for treating glioblastoma
Has the secret of the immortality cancer switch been unlocked?
Breast
Palbociclib halts tumor growth in early breast cancer patients
NCRI 2018: Women who are ‘larks’ have a lower risk of developing breast cancer, study suggests
ESMO18: New combination therapy for breast cancer may prolong survival
Colorectal
NCRI 2018: Inherited bowel cancer may be preventable by treatment of pre-cancerous stem cells
Data-driven blood test could be a step towards personalized treatment for bowel cancer
Endocrine
NICE recommends new first-line treatment Lenvima against advanced liver cancer
NCRI 2018: HiLo trial suggests low risk thyroid cancer patients can receive lower doses of radiation
Gastrointestinal
Genetic test could predict stomach or esophageal cancer relapse
A remarkable insight into the cancer journey of Barbara Moss
Conference Chair highlights: World Congress on Gastrointestinal Cancer
Genitourinary
Could urine liquid biopsies help monitor bladder cancer treatment?
NICE approves atezolizumab for advanced bladder cancer patients on the NHS
Gynecologic
SOLO-1: practice-changing results for advanced ovarian cancer patients with BRCA mutation
Vistusertib with paclitaxel shows promise for ovarian and lung cancer in early trial
Head and neck
Pembrolizumab extends survival for advanced head and neck cancer patients
KEYNOTE-048: pembrolizumab changes the rules for head and neck cancer patients
Diabetics face a higher risk of mouth cancer, with women more at risk
Hematologic
ASH 2018 round-up: practice-changing data for leukemia subtype and more
Personalized prediction scheme for myeloproliferative neoplasms developed
NHS England strikes deal for ground-breaking CAR-T therapy in a new European first
Lung
Keytruda® gets the green light from NICE for untreated lung cancer
GioTag: results of real-world study of treatment sequencing in EGFR mutation-positive lung cancer
Pancreatic
Unraveling the tumor biology of pancreatic cancer with Harpreet Wasan
Emerging treatment options for pancreatic cancer with Thomas Seufferlein
ESMO WCGI: Study highlights first-line treatment variations for pancreatic cancer
Prostate
Court invalidates patent for prostate cancer drug Zytiga®
Circulating tumor cells: researchers develop mechanism for characterizing function
Rare tumors
Promising Phase I trial for anti-HER2 antibody
Osteoblastoma genetic marker shows promise for identifying aggressive tumors
Skin
NCRI 2018: Male melanoma deaths rising, study reports
FDA approves first and only treatment for advanced cutaneous squamous cell carcinoma
